<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0" nsmap="{'media': 'http://search.yahoo.com/mrss/'}"><channel><title>Raichur News Feed</title><link>https://news.google.com/rss/search?q=raichur&amp;hl=en-US&amp;gl=US&amp;ceid=US:en</link><description>Latest news about Raichur</description><language>en-US</language><item><title>Shilpa Pharma Lifesciences Clears USFDA Inspection at Raichur Unit-2</title><link>https://www.indiainfoline.com/news/business/shilpa-pharma-lifesciences-clears-usfda-inspection-at-raichur-unit-2</link><description>&lt;![CDATA[Shilpa Medicare Ltd filed that its 100% owned subsidiary – Shilpa Pharma Lifesciences Ltd has successfully passed the inspection by the US Food and Drug Administration (USFDA) at its Unit-2 facility located in Raichur.

The inspection was conducted from March 10 to March 14, 2025, and concluded without any Form 483 observations. It’s the second consecutive no-finding inspection at Unit-2, further reinforcing the company’s commitment to regulatory compliance.

No regulatory issues were raised by ...]]&gt;</description><media:content url="https://prod-iifl-assets.storage.googleapis.com/2024/08/Pharma-768x432.jpg.webp" medium="image" /></item></channel></rss>